MétaCan
Menu
Back to cohort

Vascular improvement with olmesartan medoxomil

2005· article· en· W2162305848 on OpenAlexaff
H YOKOYAMA, Richard Smith, David B. Averill, Ernesto L. Schiffrin, Carlos M. Ferrario

Bibliographic record

VenueAmerican Journal of Hypertension · 2005
Typearticle
Languageen
FieldMedicine
TopicBlood Pressure and Hypertension Studies
Canadian institutionsMontreal Clinical Research Institute
Fundersnot available
KeywordsMedicineOlmesartanMyographIrbesartanBlood pressureAngiotensin IIInternal medicineEnd organ damageAngiotensin II receptor type 1UrologyCardiologyEndocrinologyEndothelium

Abstract

fetched live from OpenAlex

To inhibit the incidence of end organ damage it is apparent that lowering blood pressure (BP) in of itself may not be sufficient. Attenuation of the effects of angiotensin II (AII) has proven essential in slowing progression of heart and kidney target organ damage. As vascular remodeling and endothelial dysfunction precede the development of hypertension and organ damage, the blockade of AII at the AT1 receptor with an angiotensin receptor blocker may prove efficacious in reversing vascular pathology and end organ damage. In this study 100 non-diabetic, class I essential hypertensive patients were randomized to either atenolol 100 mg or olmesartan 40 mg plus a fixed schedule of secondary agents as needed to achieve BP control for one year. After a four week washout and at week 52 of the study vascular structure was assessed by direct measurement of wall dimensions on a pressurized myograph in small resistance vessels obtained from gluteal subcutaneous fat biopsies on 49 patients. Vascular structure of 11 normotensive subjects is noted for comparison. Patient demographics were: 39 % women; mean age 55, range 38–67; mean BMI 29 kg/m2; mean cholesterol 211 mg/dL; potassium 4.3 mEq/dL; mean creatinine 0.8 mg/dL; both arms had similar characteristics. At a comparable level of blood pressure control (mean for study group 122/77±11/6 mmHg), AT1 blockade induced a decrease in the wall to lumen ratio percentage from 14.9±0.8% to 11.1± 0.5%, a value nearly identical to that of the normotensive subjects, 11.0± 0.6%. This was significantly different (p<0.001) than the lack of effect in reducing remodeling obtained with beta blockade wherein there was essentially no change (16.0± 0.8 % to 15.5± 0.6%). Blockade of the AT1 receptor with olmesartan medoxomil produces vascular remodeling of a resistance vessel virtually to normal whereas atenolol has little or no effect.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Non-randomized trial · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.005
Threshold uncertainty score0.017

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0050.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.016
GPT teacher head0.234
Teacher spread0.218 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNon-randomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2005
Admission routes1
Has abstractyes

Explore more

Same venueAmerican Journal of HypertensionSame topicBlood Pressure and Hypertension StudiesFrench-language works237,207